Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
EVP Research
-
Issuer Symbol
-
IONS on Nasdaq
Eric Swayze - trading volume in the past year for IONIS PHARMACEUTICALS INC
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
47,747 |
$3,959,825 |
$82.93 |
30 Jan 2026 |
Direct |
|
|
| Performance Restricted Stock Units |
90,282 |
$2,114,365 |
$32.79 |
15 Jan 2026 |
Direct |
Common Stock |
|
| Restricted Stock Unit |
48,926 |
$1,987,631 |
$32.79 |
15 Jan 2026 |
Direct |
Common Stock |
|
| Common Stock |
318 |
$25,156 |
$79.11 |
29 Jan 2026 |
by Son |
|
|
| Restricted Stock Unit |
611 |
$20,395 |
$32.79 |
15 Jan 2026 |
by Son |
Common Stock |
|
| Non-Qualified Stock Option (right to buy) |
19,350 |
|
|
02 Jan 2026 |
Direct |
Common Stock |
|
| Non-Qualified Stock Option (right to buy) |
150 |
|
|
02 Jan 2026 |
by Son |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.